Virus Stresses China As Emerging Initial Response Provokes Anger
Confirmed Cases Nudge 10,000
China research paper suggesting early cover-up of newly identified coronavirus stirs controversy and anger as reported China cases approach 10,000 and global spread continues.
You may also be interested in...
With the threat of potentially hefty fines, China's newly passed Biosecurity Law will fundamentally change how the life science sector handles human genetic resources over years to come, legal experts say.
Curon thinks tenalisib can offer a differentiated and safe new therapy for hematologic cancers such as multiple forms of lymphoma. Axis and PharmaEssentia team up on TCR therapy R&D in Taiwan.
Recent moves show Chinese biotech firms are increasingly looking to go global by recruiting world-class development talent, and J&J names new APAC pharma head.